Table 4.
Estimated changes from baseline in muscle performance and physical function outcomes by treatment arm
Variable | Placebo | 1 mg/day | 5 mg/day | 15 mg/day | P value (5 mg/day vs Placebo) | P value (any effect) |
---|---|---|---|---|---|---|
Gait speed in 6-minute walk, m/sec | 0.06 (0.02, 0.10) | 0.08 (0.04, 0.13) | 0.09 (0.05, 0.12) | 0.06 (−0.001, 0.12) | 0.32 | 0.71 |
Unloaded 50m walk gait speed, m/sec | 0.06 (−0.01, 0.12) | 0.13 (0.05, 0.20) | 0.03 (−0.03, 0.09) | 0.08 (−0.03, 0.19) | 0.52 | 0.26 |
Loaded 50m walk gait speed, m/sec | 0.05 (−0.02, 0.12) | 0.12 (0.03, 0.20) | 0.05 (−0.02, 0.12) | 0.11 (0.001, 0.22) | 0.93 | 0.44 |
Unloaded stair climb power, watts | 7.2 (−35.2, 49.5) | 26.6 (−26.1, 79.2) | 0.14 (−40.5, 40.7) | 45.0 (−26.8, 116.9) | 0.80 | 0.65 |
Loaded stair climb power, watts | 10.9 (−31.7, 53.5) | −6.6 (−59.2, 45.9) | −6.8 (−54.1, 40.6) | 72.2 (2.99, 141.4) | 0.56 | 0.25 |
Leg press 1-RM, N | 7.5 (−87.9, 102.9) | 138.6 (17.9, 259.3) | 55.6 (−28.0, 139.2) | 98.9 (−35.6, 233.5) | 0.44 | 0.30 |
The data are point estimates and 95% CIs extracted from mixed model framework. P values for overall and for prespecified comparison of 5-mg vs placebo.
Abbreviation: 1-RM, one repetition maximum in Newtons.